109 related articles for article (PubMed ID: 30006881)
1. Specific Features of Transcription Activity of Cancer-Testis Antigens in Patients with Metastatic and Non-Metastatic Breast Cancer.
Vodolazhsky DI; Kutilin DS; Mogushkova KA; Kit OI
Bull Exp Biol Med; 2018 Jul; 165(3):382-385. PubMed ID: 30006881
[TBL] [Abstract][Full Text] [Related]
2. Cancer-testis antigen expression in synovial sarcoma: NY-ESO-1, PRAME, MAGEA4, and MAGEA1.
Iura K; Maekawa A; Kohashi K; Ishii T; Bekki H; Otsuka H; Yamada Y; Yamamoto H; Harimaya K; Iwamoto Y; Oda Y
Hum Pathol; 2017 Mar; 61():130-139. PubMed ID: 27993576
[TBL] [Abstract][Full Text] [Related]
3. [Regulation of Gene Expression of Cancer/Testis Antigens in Colorectal Cancer Patients].
Kutilin DS
Mol Biol (Mosk); 2020; 54(4):580-595. PubMed ID: 32799221
[TBL] [Abstract][Full Text] [Related]
4. Expression of cancer-testis antigens MAGEA1, MAGEA3, ACRBP, PRAME, SSX2, and CTAG2 in myxoid and round cell liposarcoma.
Hemminger JA; Toland AE; Scharschmidt TJ; Mayerson JL; Guttridge DC; Iwenofu OH
Mod Pathol; 2014 Sep; 27(9):1238-45. PubMed ID: 24457462
[TBL] [Abstract][Full Text] [Related]
5. Expression and Prognostic Relevance of GAGE1 and XAGE1 Cancer/Testis Antigens in Head and Neck Squamous Cell Carcinoma.
Karia BTR; Zamuner FT; Carlin V; de Oliveira CZ; Carvalho AL; Vettore AL
Curr Mol Med; 2017; 17(10):707-717. PubMed ID: 29577858
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of cancer/testis antigen expression in advanced stage multiple myeloma patients.
Andrade VC; Vettore AL; Felix RS; Almeida MS; Carvalho F; Oliveira JS; Chauffaille ML; Andriolo A; Caballero OL; Zago MA; Colleoni GW
Cancer Immun; 2008 Feb; 8():2. PubMed ID: 18237105
[TBL] [Abstract][Full Text] [Related]
7. Aberrant demethylation and expression of MAGEB2 in a subset of malignant peripheral nerve sheath tumors from neurofibromatosis type 1.
Nobeyama Y; Nakagawa H
J Dermatol Sci; 2016 Feb; 81(2):118-23. PubMed ID: 26642794
[TBL] [Abstract][Full Text] [Related]
8. Expression of NY-ESO-1, MAGE-A3, PRAME and WT1 in different subgroups of breast cancer: An indication to immunotherapy?
Tessari A; Pilla L; Silvia D; Duca M; Paolini B; Carcangiu ML; Mariani L; de Braud FG; Cresta S
Breast; 2018 Dec; 42():68-73. PubMed ID: 30189381
[TBL] [Abstract][Full Text] [Related]
9. Expression of MAGE and BAGE genes in Japanese breast cancers.
Fujie T; Mori M; Ueo H; Sugimachi K; Akiyoshi T
Ann Oncol; 1997 Apr; 8(4):369-72. PubMed ID: 9209667
[TBL] [Abstract][Full Text] [Related]
10. Cancer/testis antigen SSX2 enhances invasiveness in MCF-7 cells by repressing ERα signaling.
Chen L; Zhou WB; Zhao Y; Liu XA; Ding Q; Zha XM; Wang S
Int J Oncol; 2012 Jun; 40(6):1986-94. PubMed ID: 22344619
[TBL] [Abstract][Full Text] [Related]
11. Cancer-testis antigens and ING1 tumor suppressor gene product are breast cancer antigens: characterization of tissue-specific ING1 transcripts and a homologue gene.
Jäger D; Stockert E; Scanlan MJ; Güre AO; Jäger E; Knuth A; Old LJ; Chen YT
Cancer Res; 1999 Dec; 59(24):6197-204. PubMed ID: 10626813
[TBL] [Abstract][Full Text] [Related]
12. Prospective study on the expression of cancer testis genes and antibody responses in 100 consecutive patients with primary breast cancer.
Mischo A; Kubuschok B; Ertan K; Preuss KD; Romeike B; Regitz E; Schormann C; de Bruijn D; Wadle A; Neumann F; Schmidt W; Renner C; Pfreundschuh M
Int J Cancer; 2006 Feb; 118(3):696-703. PubMed ID: 16094643
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of MAGEA2 has a prognostic significance and is a potential therapeutic target for patients with lung cancer.
Ujiie H; Kato T; Lee D; Hu HP; Fujino K; Kaji M; Kaga K; Matsui Y; Yasufuku K
Int J Oncol; 2017 Jun; 50(6):2154-2170. PubMed ID: 28498455
[TBL] [Abstract][Full Text] [Related]
14. Identification of tumor-restricted antigens NY-BR-1, SCP-1, and a new cancer/testis-like antigen NW-BR-3 by serological screening of a testicular library with breast cancer serum.
Jäger D; Unkelbach M; Frei C; Bert F; Scanlan MJ; Jäger E; Old LJ; Chen YT; Knuth A
Cancer Immun; 2002 Jun; 2():5. PubMed ID: 12747750
[TBL] [Abstract][Full Text] [Related]
15. Preferential expression of cancer/testis genes in cancer stem-like cells: proposal of a novel sub-category, cancer/testis/stem gene.
Yamada R; Takahashi A; Torigoe T; Morita R; Tamura Y; Tsukahara T; Kanaseki T; Kubo T; Watarai K; Kondo T; Hirohashi Y; Sato N
Tissue Antigens; 2013 Jun; 81(6):428-34. PubMed ID: 23574628
[TBL] [Abstract][Full Text] [Related]
16. Expression of Cancer Testis Antigens in Colorectal Cancer: New Prognostic and Therapeutic Implications.
Tarnowski M; Czerewaty M; Deskur A; Safranow K; Marlicz W; Urasińska E; Ratajczak MZ; Starzyńska T
Dis Markers; 2016; 2016():1987505. PubMed ID: 27635108
[TBL] [Abstract][Full Text] [Related]
17. The melanoma antigen gene as a surveillance marker for the detection of circulating tumor cells in patients with breast carcinoma.
Kwon S; Kang SH; Ro J; Jeon CH; Park JW; Lee ES
Cancer; 2005 Jul; 104(2):251-6. PubMed ID: 15937912
[TBL] [Abstract][Full Text] [Related]
18. Circulating tumor cells (CTCs) detected by triple-marker EpCAM, CK19, and hMAM RT-PCR and their relation to clinical outcome in metastatic breast cancer patients.
Zhao S; Yang H; Zhang M; Zhang D; Liu Y; Liu Y; Song Y; Zhang X; Li H; Ma W; Zhang Q
Cell Biochem Biophys; 2013 Mar; 65(2):263-73. PubMed ID: 22990361
[TBL] [Abstract][Full Text] [Related]
19. Cancer-Testis Antigens as New Candidate Diagnostic Biomarkers for Transitional Cell Carcinoma of Bladder.
Afsharpad M; Nowroozi MR; Mobasheri MB; Ayati M; Nekoohesh L; Saffari M; Zendehdel K; Modarressi MH
Pathol Oncol Res; 2019 Jan; 25(1):191-199. PubMed ID: 29058301
[TBL] [Abstract][Full Text] [Related]
20. MAGE-D4B is a novel marker of poor prognosis and potential therapeutic target involved in breast cancer tumorigenesis.
Germano S; Kennedy S; Rani S; Gleeson G; Clynes M; Doolan P; McDonnell S; Hughes L; Crown J; O'Driscoll L
Int J Cancer; 2012 May; 130(9):1991-2002. PubMed ID: 21618523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
